Brenton Ahrens

Direktor/Vorstandsmitglied bei Iterum Therapeutics US Holding Ltd.

Finance

Ursprung des Netzwerks ersten Grades von Brenton Ahrens

Einheit	Art der Einheit	Industrie
Iterum Therapeutics US Holding Ltd. Iterum Therapeutics US Holding Ltd. Financial ConglomeratesFinance Iterum Therapeutics US Holding Ltd. operates as a clinical-stage pharmaceutical company. The company was founded in 2018 and is headquartered in Chicago, IL. 8	Subsidiary	Financial Conglomerates	8

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Brenton Ahrens

Unternehmen	Sektor	Verknüpfte Personen	Hauptposition
MOMENTA PHARMACEUTICALS, INC.	Pharmaceuticals: Major	Corey Fishman	Director/Board Member
COLLEGIUM PHARMACEUTICAL, INC.	Pharmaceuticals: Major	Patrick Heron	Director/Board Member
Cerexa, Inc. Cerexa, Inc. Pharmaceuticals: MajorHealth Technology Cerexa, Inc. develops biopharmaceutical products. It is focuses on developing, acquiring and commercializing antibiotics to treat life-threatening, hospital-based infections. Cerexa's compound PPI-0903 is a cephalosporin used in treatment for complicated skin and skin-structure infections, as well as community-acquired and hospital-acquired pneumonias. The company was founded in 2005 and is headquartered in Alameda, CA.	Pharmaceuticals: Major	Ron Hunt Patrick Heron	Director/Board Member Director/Board Member
AURA BIOSCIENCES, INC.	Biotechnology	Mark Chin	Director/Board Member
PreCision Dermatology, Inc. PreCision Dermatology, Inc. Pharmaceuticals: MajorHealth Technology PreCision Dermatology, Inc. developed skincare therapies. It offered pharmaceutical products for skin barrier restoration, dermatoses, rosacea, acne, seborrheic dermatitis, and scaling associated with hyperkeratotic skin. The company was founded by Jeffrey M. Nugent in 2010 and was headquartered in Cumberland, RI.	Pharmaceuticals: Major	Patrick Heron	Director/Board Member
Calibrium LLC Calibrium LLC Pharmaceuticals: MajorHealth Technology Calibrium LLC develops biopharmaceuticals and diabetic drugs. The company is a biotech company that develops novel peptides that helps in the treatment of diabetes and related metabolic diseases. The company was founded by Fritz French and Richard DiMarch in 2013 and is headquartered in Carmel, IN.	Pharmaceuticals: Major	Patrick Heron	Director/Board Member
Sofinnova Investments, Inc. Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California.	Investment Managers	James Healy	Private Equity Investor
McKinsey & Co., Inc. McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY.	Miscellaneous Commercial Services	Patrick Heron	Corporate Officer/Principal
MedPointe, Inc. MedPointe, Inc. Pharmaceuticals: MajorHealth Technology MedPointe, Inc. develops, markets, and sells therapeutics. The company's products include respiratory, allergy, central nervous system, cough/cold, and pediatric products. The company was founded by James S. Burns and Anthony H. Wild in 2001 and is headquartered in Somerset, NJ.	Pharmaceuticals: Major	Patrick Heron Corey Fishman	Director/Board Member Director of Finance/CFO
The General Hospital Corp. The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA.	Hospital/Nursing Management	Patrick Heron	Corporate Officer/Principal
Purdue University	College/University	Corey Fishman	Graduate Degree
Amunix, Inc. Amunix, Inc. Pharmaceuticals: MajorHealth Technology Amunix, Inc. develops protein pharmaceuticals. It offers XTEN which is hydrophilic, unstructured, biodegradable polypeptides that impart a number of favorable properties upon the molecules to which they are attached. The company was founded by Volker Schellenberger and Willem Stemmer in 2006 and is headquartered in Mountain View, CA.	Pharmaceuticals: Major	Patrick Heron	Director/Board Member
Moximed, Inc. Moximed, Inc. Medical SpecialtiesHealth Technology Moximed, Inc. develops minimally invasive, joint sparing solutions for patients with knee osteoarthritis. Its Osteoarthritis treatment can minimize joint pain, restore normal activity levels, and slow down disease progression. The company was founded by Anton G. Clifford in 2006 and is headquartered in Hayward, CA.	Medical Specialties	Patrick Heron	Director/Board Member
Meda Pharmaceuticals, Inc. Meda Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Meda Pharmaceuticals, Inc. manufactures and develops drugs and pharmaceuticals. The firm specializes in respiratory, allergy, central nervous system, and cough-cold products. Its products include Aerospan, Anadrol-50, Astelin, Astepro, BiferaRx, Butisol Sodium, Cesame, Colyte, Cortifoam, Demadex, Depen, Dipentum, Edlua, Rowasa, Optivar, Soma and Levsin. The company was founded in 2001 and is headquartered in Somerset, NJ.	Pharmaceuticals: Major	Corey Fishman	Director of Finance/CFO
IGNYTA INC	Biotechnology	Patrick Heron	Director/Board Member
The Wharton School of the University of Pennsylvania	College/University	Ron Hunt Mark Chin	Masters Business Admin Masters Business Admin
Harvard Business School	College/University	Patrick Heron	Masters Business Admin
ARMO BIOSCIENCES INC	Pharmaceuticals: Major	Patrick Heron	Director/Board Member
CIDARA THERAPEUTICS, INC.	Pharmaceuticals: Other	Patrick Heron	Director/Board Member
IMAGO BIOSCIENCES, INC.	Biotechnology	Patrick Heron	Director/Board Member
VAXCYTE, INC.	Biotechnology	Patrick Heron	Director/Board Member
TOBIRA THERAPEUTICS INC	Pharmaceuticals: Major	Patrick Heron	Director/Board Member
Iterum Pharmaceuticals LLC Iterum Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Iterum Pharmaceuticals LLC manufactures pharmaceutical products. The company is headquartered in Chicago, IL.	Pharmaceuticals: Major	Corey Fishman	Chief Executive Officer
ITERUM THERAPEUTICS PLC	Pharmaceuticals: Major	James Healy Ron Hunt Patrick Heron Corey Fishman David Kelly Mark Chin Judith Matthews Louise Barrett	Director/Board Member Chairman Director/Board Member Founder Director/Board Member Director/Board Member Director of Finance/CFO General Counsel
HARPOON THERAPEUTICS, INC.	Biotechnology	Ron Hunt Mark Chin	Chairman Director/Board Member
Zavante Therapeutics, Inc. Zavante Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Zavante Therapeutics, Inc. manufactures pharmaceutical products. Its product ZOLYD is an investigational, first-in-class epoxide antibiotic with a spectrum of bactericidal Gram-negative and Gram-positive activity, including activity against most contemporary MDR strains that threaten hospitalized patients. The company was founded by Cam L. Garner, Evelyn Ellis-Grosse and Theodore R. Schroeder in 2013 and is headquartered in San Diego, CA.	Pharmaceuticals: Major	Patrick Heron	Director/Board Member
Depixus SAS Depixus SAS Miscellaneous Commercial ServicesCommercial Services Depixus SAS is a life science technology company based in Paris, France. Depixus is pioneering ground-breaking magna™ technology based on magnetic force spectroscopy, revealing dramatic new insights into complex biomolecular interactions at the single molecule level. The French company was founded by Gordon Hamilton and has been the CEO since incorporation.	Miscellaneous Commercial Services	Mark Chin	Director/Board Member
Scout Bio, Inc. Scout Bio, Inc. Pharmaceuticals: MajorHealth Technology Scout Bio, Inc. operates as a biotechnology company that focuses on the innovation of pet medicine by delivering a pipeline of one-time therapeutics for major chronic pet health conditions. It also specializes in gene therapy, veterinary product development and biotechnology investment. The company was founded by James M. Wilson in 2016 and is headquartered in Philadelphia, PA.	Pharmaceuticals: Major	Patrick Heron	Director/Board Member
University of Illinois At Urbana–Champaign	College/University	Corey Fishman Judith Matthews	Undergraduate Degree Undergraduate Degree
Iterum Therapeutics US Ltd. Iterum Therapeutics US Ltd. Pharmaceuticals: MajorHealth Technology Iterum Therapeutics US Ltd. manufactures pharmaceutical products. The company was founded in 2015 and is headquartered in Chicago, IL.	Pharmaceuticals: Major	Corey Fishman Judith Matthews	Chief Executive Officer President
Iterum Therapeutics International Ltd. Iterum Therapeutics International Ltd. Pharmaceuticals: MajorHealth Technology Iterum Therapeutics International Ltd. engages in the development of clinical-stage pharmaceutical products. The company was founded in 2015 and is headquartered in Dublin, Ireland.	Pharmaceuticals: Major	James Healy Ron Hunt Patrick Heron Corey Fishman David Kelly Mark Chin Judith Matthews Louise Barrett	Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member
Recida Therapeutics, Inc. Recida Therapeutics, Inc. BiotechnologyHealth Technology Recida Therapeutics, Inc. engages in the development of novel therapeutics. The company was founded by Yigong Ge, Aditya Kohli, and David A. Socks in 2016 and is headquartered in Menlo Park, CA.	Biotechnology	Patrick Heron	Director/Board Member
ARCUTIS BIOTHERAPEUTICS, INC.	Pharmaceuticals: Major	Patrick Heron	Chairman
MIRUM PHARMACEUTICALS, INC.	Pharmaceuticals: Major	Patrick Heron	Director/Board Member
PASSAGE BIO, INC.	Biotechnology	Patrick Heron	Director/Board Member
MBX Biosciences, Inc. MBX Biosciences, Inc. Electronic Equipment/InstrumentsElectronic Technology MBX Biosciences, Inc. operates as a preclinical-stage biotech company. It creates therapies to treat rare endocrine diseases. The company was founded by Peter Kent Hawryluk and Timothy Knickerbocker and is headquartered in Carmel, IN.	Electronic Equipment/Instruments	Patrick Heron	Director/Board Member
PYXIS ONCOLOGY, INC.	Pharmaceuticals: Major	Mark Chin	Director/Board Member
Disc Medicine Opco, Inc. Disc Medicine Opco, Inc. BiotechnologyHealth Technology Disc Medicine, Inc. engages in the development of therapies addressing ineffective red blood cell production in hematologic diseases. Its product pipeline includes anti-hemojuvelin antibody and Matriptase-2 inhibitor. The company was founded by Brian MacDonald and is headquartered in Cambridge, MA.	Biotechnology	Mark Chin	Director/Board Member
Iterum Therapeutics Bermuda Ltd. Iterum Therapeutics Bermuda Ltd. Pharmaceuticals: MajorHealth Technology Iterum Therapeutics Bermuda Ltd. is an emerging growth company, which engages in the provision of financing activities. The company was founded on November 6, 2019 and is headquartered in Hamilton, Bermuda.	Pharmaceuticals: Major	David Kelly Judith Matthews Louise Barrett	Director/Board Member Director/Board Member Director/Board Member
DURATA THERAPEUTICS INC	Pharmaceuticals: Major	James Healy Ron Hunt Corey Fishman Judith Matthews	Director/Board Member President Director of Finance/CFO Corporate Officer/Principal
HILLEVAX, INC.	Biotechnology	Patrick Heron	Director/Board Member
Arix Bioscience /Venture Capital/ Arix Bioscience /Venture Capital/ Investment ManagersFinance Arix Bioscience /Venture Capital/ (Arix Bioscience) is a venture capital subsidiary of Arix Bioscience Plc founded in 2015 by Christopher Thomas Evans, Jonathan M. Peacock and Joseph Anderson. The firm is headquartered in London, United Kingdom with an additional offices in New York.	Investment Managers	Mark Chin	Private Equity Investor